Mindstrong Health Firm Receives $ 14 Million Fund for its New Series-A

Mindstrong Health is a startup firm that renders neuropsychiatric diagnosis and treatment through the utility of smartphones. In June 2017, the firm was delighted to announce that it had secured a $14 million-dollar worth of fund from business entities that included; ARCH Adventure Associates, Optum Ventures, One Mind Brain Health Impact Company and Foresite Capital.

The firm devised a stage that enabled the diagnosis of mental disorders through tracking patients’ patterns of typing and scrolling on a smartphone, which projects the cognitive functions of an individual. The technology offers information regarding sensitive dispositions and cognitive biomarkers. These are often depicted from elements like speed, function, and memory.

The platform has provided a revolutionary means of treating mental disorders, and according to the CEO and founder of Mindstrong Health, Paul Dagum, every contemporary healthcare bases its facts on objective measurement, yet provisions of mental care have been limited to clinical analyses in a medical setting. He also exclaimed,” For better mental care treatment procedures, it is crucial to devise other objective measures of alleviating chronic conditions such as diabetes and cardiovascular disorders. Mindstrong provides continuous, goal-oriented measures of character and cognitive functions with an insightful and resolution level that was previously inaccessible.”

Mr. Jim Tananbaum, CEO, and MD of Foresite Capital applauded the Mindstrong Health founders for the remarkable digital health care platform. “Mindstrong brings a unique and expansive understanding of the drawbacks that derail the dispensation of mental care,” he said.

About Jim Tananbaum

He is the CEO and founder of Foresite Capital, and a renowned industrialist with more than 25 years of experience as a healthcare entrepreneur and investor. His major drive is to provide strategic, financial and operational business opportunities to create a medical franchise business. For more details visit Medium.

During his career, he has played a significant role in enabling the startup and growth of health care firm in virtually of segments of the medical industry. In January 1993, he co-founded Gel Tex, where he also sat as a board member, before his affiliation with Sierra Ventures. From the year 1997-2000, he served as the CEO, Theravance. In 2001, he co-founded and managed Prospect Venture Associates.

Jim is a graduate of Yale University with a BS, BSEE degree in math and computer science. He also obtained an MSc, Information theory and an MD degree from Massachusetts Institute of Technology and Harvard School of Medicine respectively.

Visit officialjimtananbaum.com

Ref: https://www.linkedin.com/in/jim-tananbaum-a7562a7/

One comment

  • Elisabeth Dario
    July 30, 2018 - 6:49 pm | Permalink

    A speaker at the joint venture commission has been truly deserving to have so much in doing business on small scales. Everything about the dissertation help uk review has aimed at the very best since it is not easy really. Towards the end, I think understanding on the fortunate things that most people will have MIT wealth of knowledge.

  • Comments are closed.